Stocks and securities in focus
Security | Change (%) | 1w | 1m | 1y | YTD ▼ | 3y | 5y |
---|---|---|---|---|---|---|---|
Viking Therapeutics Inc | 7.230% | 16.667% | -7.290% | 291.653% | 297.140% | 1294.658% | - |
Brainstorm Cell | -5.760% | -2.456% | -18.607% | -82.011% | 114.009% | -83.339% | - |
Geron Corp. | 7.910% | 2.018% | 16.305% | 60.965% | 79.776% | 184.177% | 114.554% |
Avid Bioservices Inc | 3.170% | 9.244% | 1.563% | -61.310% | 6.557% | -63.068% | 49.683% |
Akebia Therapeutics Inc. | 0.240% | -1.887% | -33.475% | 72.614% | 6.485% | -52.727% | - |
Ardelyx Inc. | 3.600% | -1.640% | -12.849% | 41.749% | 3.737% | -16.140% | - |
Fate Therapeutics Inc. | -0.060% | -21.195% | -43.894% | -32.694% | -0.253% | -95.334% | - |
Transgene S.A. | -4.120% | -10.526% | 15.625% | -29.799% | -6.119% | -49.376% | -56.471% |
AnaptysBio Inc | -2.790% | -5.435% | -12.121% | -7.937% | -10.309% | -10.769% | - |
Genfit S.A. | -1.090% | 0.475% | -4.085% | -6.352% | -12.067% | -11.502% | -85.986% |
Novavax Inc. | 3.830% | 1.832% | -13.246% | -44.288% | -14.703% | -97.921% | -57.208% |
Sangamo Therapeutics Inc. | 4.960% | 1.166% | -13.017% | -66.603% | -15.528% | -95.247% | -95.507% |
Insmed Inc. | -3.330% | 2.655% | -7.200% | 31.818% | -18.881% | -19.444% | -15.406% |
Pacira Pharmaceuticals | -0.840% | -2.479% | -8.527% | -39.487% | -20.805% | -53.725% | -32.935% |
TG Therapeutics Inc. | -1.700% | -2.811% | -11.784% | -37.174% | -21.644% | -65.730% | - |
Salarius Pharmaceuticals Inc. | 1.400% | 3.333% | 6.373% | -63.833% | -21.802% | -98.281% | -99.993% |
Biocryst Pharmaceuticals | 0.030% | -6.702% | -16.634% | -43.726% | -29.816% | -62.089% | -43.824% |
Abeona Therapeutics Inc. | 6.080% | -56.901% | -56.534% | 9.052% | -35.032% | -91.374% | - |
Esperion Therapeutis.Inc. | -3.810% | -2.985% | -30.256% | 60.753% | -38.275% | -92.220% | -95.406% |
Bastide Le Confort | 0.600% | 9.881% | 14.560% | -39.345% | -39.675% | -63.621% | - |
Immunogen Inc. | 0.070% | - | - | - | - | - | - |
Biodelivery Sciences | -0.980% | - | - | - | - | - | - |